» Articles » PMID: 28933131

The Clinical Spectrum of Primary Sjögren's Syndrome: Beyond Exocrine Glands

Overview
Journal Reumatismo
Publisher PagePress
Specialty Rheumatology
Date 2017 Sep 22
PMID 28933131
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Although primary Sjögren's syndrome (pSS) is a mild indolent chronic disease mainly characterized by mucosal dryness in the majority of cases, a consistent subgroup of patients display extra-glandular manifestations. Virtually any organs and systems can be affected, leading to a more serious disease prognosis. Therefore, the prompt identification of patients at higher risk of extra-glandular manifestations is necessary to start a thorough follow up and an aggressive treatment. The aim of this review article is to provide an overview of epidemiological, clinical and serological features of extra-glandular manifestations in pSS as well as current knowledge about putative biomarkers useful in clinical practice.

Citing Articles

CD40 ligand antagonist dazodalibep in Sjögren's disease: a randomized, double-blinded, placebo-controlled, phase 2 trial.

St Clair E, Baer A, Ng W, Noaiseh G, Baldini C, Tarrant T Nat Med. 2024; 30(6):1583-1592.

PMID: 38839899 PMC: 11186761. DOI: 10.1038/s41591-024-03009-3.


Comprehensive analysis of the clinical manifestations and hematological parameters associated with secondary immune thrombocytopenia in patients with primary Sjögren syndrome: An observational study.

Yang W Medicine (Baltimore). 2024; 103(19):e37909.

PMID: 38728456 PMC: 11081593. DOI: 10.1097/MD.0000000000037909.


The association between primary Sjogren's syndrome and non-Hodgkin's lymphoma: a systematic review and meta-analysis of cohort studies.

Ansari N, Salesi M Clin Rheumatol. 2024; 43(7):2177-2186.

PMID: 38722505 DOI: 10.1007/s10067-024-06993-6.


Efficacy and safety of remibrutinib, a selective potent oral BTK inhibitor, in Sjögren's syndrome: results from a randomised, double-blind, placebo-controlled phase 2 trial.

Dorner T, Kaul M, Szanto A, Tseng J, Papas A, Pylvaenaeinen I Ann Rheum Dis. 2023; 83(3):360-371.

PMID: 37932009 PMC: 10894844. DOI: 10.1136/ard-2023-224691.


Diagnostic Value of Labial Minor Salivary Gland Biopsy: Histological Findings of a Large Sicca Cohort and Clinical Associations.

Triantafyllias K, Bach M, Otto M, Schwarting A Diagnostics (Basel). 2023; 13(19).

PMID: 37835860 PMC: 10573002. DOI: 10.3390/diagnostics13193117.